title: [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
abstract: Personal experience on the use of 111In-DTPA-octreotide scintigraphy (Octreoscan) in the staging of neuroendocrine and non-neuroendocrine tumors of the lung is reported. From July 1995 to May 1996 26 scintigraphic studies were performed in patients affected by lung cancer at the Department of Thoracic Surgery and at the Service of Nuclear Medicine of the University of Turin. The scintigraphy allowed to detect the lesion in all the neuroendocrine tumors and in 63.2% of the non neuroendocrine ones. Their preliminary results are discussed and stress is laid on the importance of this scintigraphic procedure in the staging and the follow-up of neoplastic patients.
authors.affiliation: Cattedra di Chirurgia Toracica, Università degli Studi, Torino.
authors.forename: A
authors.initials: A
authors.lastname: Oliaro
authors.forename: P L
authors.initials: PL
authors.lastname: Filosso
authors.forename: M
authors.initials: M
authors.lastname: Bellò
authors.forename: C
authors.initials: C
authors.lastname: Casadio
authors.forename: A
authors.initials: A
authors.lastname: Muni
authors.forename: T
authors.initials: T
authors.lastname: Angusti
authors.forename: I
authors.initials: I
authors.lastname: Masaneo
authors.forename: G
authors.initials: G
authors.lastname: Bisi
authors.forename: G
authors.initials: G
authors.lastname: Maggi
mesh_terms: D002277:Carcinoma / Q000000981:diagnostic imaging*; D006801:Humans; D007205:Indium Radioisotopes; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging*; D015282:Octreotide / Q000031:analogs & derivatives*; D004369:Pentetic Acid / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging
chemical_list: D007205:Indium Radioisotopes; C071632:SDZ 215-811; D004369:Pentetic Acid; D015282:Octreotide
vernacular_title: Risultati preliminari sull'utilizzo della scintigrafia con octreotide radiomarcato come metodica di diagnosi delle neoplasie neuroendocrine e non neuroendocrine del polmone.